Italy· 044891048
IDELVION*1 flacone EV 2.000 Unita' Internazionali + 1 flacone 5 ml + 1 dispositivo di trasferimento con filtro + 1 siringa + 1 set + 2 tamponi + 1 cerotto
A blood coagulation factors product containing albutrepenonacog alfa, registered in Italy by CSL BEHRING GmbH, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Albutrepenonacog alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC B02BD (blood coagulation factors), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Albutrepenonacog alfa · ATC B02BD
4 / 19 countries
- Ireland
- Italyprice
- Netherlands
- Norwayprice
The record
At a glance
- Active substance
- Albutrepenonacog alfa
- Manufacturer
- CSL BEHRING GmbH
- Country
- Italy (IT)
- ATC code
- B02BD
- ATC class
- Blood coagulation factors
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic044891048IDELVION*1 flacone EV 2.000 Unita' Internazionali + 1 flacone 5 ml + 1 dispositivo di trasferimento con filtro + 1 siringa + 1 set + 2 tamponi + 1 cerottoEUR 7261.76
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Albutrepenonacog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIdelvion 1000 IUCSL Behring
- SwitzerlandIdelvion
- CzechiaIDELVIONCSL Behring GmbH, Marburg
- SpainIDELVION 1000 UI polvo y disolvente para solucion inyectableCsl Behring Gmbh
- FinlandIDELVIONCSL Behring GmbH
- FranceIDELVION 1000 UI, poudre et solvant pour solution injectableCSL BEHRING (ALLEMAGNE)
- IcelandIDELVIONCSL Behring GmbH*
- Japanアルブトレペノナコグ アルファ（遺伝子組換え）ＣＳＬベーリング
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Idelvion
- Liechtenstein · Idelvion
- Norway · Idelvion
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/734db05b-e267-4065-891a-896c5ce31e87 GET /v1/drugs/734db05b-e267-4065-891a-896c5ce31e87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 7261.76,
"source": "aifa",
"currency": "EUR",
"strength": "ALBUTREPENONACOG ALFA 2.000UI 1 USO PARENTERALE",
"substance": "Albutrepenonacog alfa",
"equivalence_group": "JJK",
"transparency_flag": null
}See everything about albutrepenonacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.